CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis - Wikidata - awgldk - TriplyDB

CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis

CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis

http://www.wikidata.org/entity/Q33873672

about

Decreased plasma levels of soluble CD18 link leukocyte infiltration with disease activity in spondyloarthritis Monocyte Heterogeneity: Consequences for Monocyte-Derived Immune Cells Recent advances in understanding and managing psoriatic arthritis Myeloid-derived suppressor cells contribute to bone erosion in collagen-induced arthritis by differentiating to osteoclasts.Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase.IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts.Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study.Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion.Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP).Increased generation of TRAP expressing multinucleated giant cells in patients with granulomatosis with polyangiitis.Biomarkers to Diagnose Early Arthritis in Patients With Psoriasis.Interactions between the immune system and bone.The role of the immune system in the physiopathology of osteoporosis Chronic Psoriatic Skin Inflammation Leads to Increased Monocyte Adhesion and Aggregation Negative regulation of osteoclast precursor differentiation by CD11b and β2 integrin-B-cell lymphoma 6 signaling Functional osteoclastogenesis: the baseline variability in blood donor precursors is not associated with age and gender.Ouabain inhibits monocyte activation in vitro: prevention of the proinflammatory mCD14(+)/CD16(+) subset appearance and cell-size progression Sources of heterogeneity in human monocyte subsets.Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis.Alliin Attenuated RANKL-Induced Osteoclastogenesis by Scavenging Reactive Oxygen Species through Inhibiting Nox1 Is psoriatic arthritis a result of abnormalities in acquired or innate immunity?Macrophage subsets and osteoimmunology: tuning of the immunological recognition and effector systems that maintain alveolar bone.Transcriptomic network support distinct roles of classical and non-classical monocytes in human.Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis.Focal bone involvement in inflammatory arthritis: the role of IL17.Monocytic cell differentiation from band-stage neutrophils under inflammatory conditions via MKK6 activation.Clinical significance of monocyte heterogeneity.Circulating monocytes: an appropriate model for bone-related study.Emerging biomarkers in psoriatic arthritis.Biomarkers in psoriatic arthritis: a systematic literature review.CD16+ monocytes in breast cancer patients: expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis.Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems.Osteoclastogenic potential of peripheral blood mononuclear cells in cleidocranial dysplasia.Autoimmune or Autoiflammatory? Bad to the Bone.Macrophage polarization and activation in response to implant debris: influence by "particle disease" and "ion disease"Peripheral blood mononuclear phagocytes from patients with chronic periodontitis are primed for osteoclast formation.The pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescence.ERBB signaling attenuates proinflammatory activation of nonclassical monocytes.Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Osteoclast Differentiation via the Ca2+ /NFATc1 Axis.Decreased tumour necrosis factor-α production by monocytes of granulomatosis with polyangiitis.

P2860

Q22000831-F98BF3ED-1660-4254-837A-E1B15385FA46 Q26740174-DE5400A2-6575-48BB-B7CD-9DD6462FCE3A Q28076527-8C657AF1-0D72-413E-B1F7-65B6F9495654 Q30278787-1F99C8A1-6D22-4323-B667-943CA74503C0 Q30478264-150C987B-0CB0-4A06-9EEF-50BAE59E7A85 Q33574203-9FE36896-17B4-4EE5-9C66-C01FE742B128 Q33764331-30FB43E3-1F22-470F-8588-45AFCA76FF72 Q34153144-7E87D8F3-0EBD-4998-B404-9E55A7766AFA Q34222920-B1525CBF-525D-4D00-B6D7-CAD0F55FFDBC Q34384535-D5D6D690-14B9-41A0-A65D-A357B9F2FD62 Q34563661-4E500E9B-3FFE-4AF2-AFB9-0BF228BF2B5C Q35825391-D655ACC4-D96D-4EB7-87EA-F524C70D3A80 Q36333478-E53FA33E-FA05-4427-90FC-229F6B88A144 Q36390768-7F2513A4-B5A7-43C6-930C-951A374FA8C5 Q36468037-718BEA17-B1A9-46E4-98E5-FF29D6410DDC Q36544723-684C7F78-5624-4C15-9F36-28FEBD5D60D5 Q36891100-77EAB0CC-97E5-47FD-812B-87A379A1F1F8 Q36935158-E1998B6F-6DFF-4B18-9BDD-66EDA4EE201D Q37115802-2C229F71-55D8-40A0-BA48-1EA27358B962 Q37286542-7ACAF803-6996-45AF-93C0-9272F3453B20 Q38004958-975545BF-0EBA-4CE1-B7FC-EB0C99242115 Q38127779-65877FEF-0DD9-422B-8AC3-58FCE5154ED2 Q38204490-F9B8FD3E-E176-481A-AFFA-A3D8D5DEF886 Q38218977-F1DD0DD5-F78D-43FB-9F2E-BD5983449672 Q38295616-DACD1F6B-C39F-4B47-B146-4CFB85E1877B Q38304270-F734CE5D-E864-4D21-8EBD-073350F78B42 Q38411099-1D415A68-F60F-4711-941E-A77124DFB3C5 Q38551006-6F64C6A3-8C6E-4EE9-8698-6ACFE013038A Q38646234-1F3F3C54-255A-42E4-BE18-A209B217F95C Q38715137-DD701E6E-CB0A-4316-894F-90DD0FFECC5F Q39584019-9AD20B2A-861A-45BB-8300-3E0A3109D380 Q41921500-6A109AEE-2F01-4535-8BC1-E6A3B9761551 Q41980849-00AAE659-F905-4098-92E5-4E13E9C4FEAF Q42095487-ADF22CFA-0406-40D7-BEDD-F5D96BC3AB44 Q42696291-1E7E24A8-D8BE-40A6-89C1-EDC60C576861 Q45272768-95E28B3E-B856-4E0E-A394-77780BEDBEAA Q49958269-F0BE5B66-4766-48D8-9A49-FC01FE3D5391 Q51123571-7245B019-F494-408F-88C9-9A4A206F63CA Q51141211-75D45C2A-FE33-4233-BEF7-0A7A623F7CF0 Q51719130-199B91ED-BD90-4140-B366-01507D17B280

P2860

CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis

http://www.wikidata.org/entity/Q33873672

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis

@ast

CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis

@en

type

label

CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis

@ast

CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis

@en

prefLabel

CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis

@ast

CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis

@en

P1433

Q33873672-332D4C49-B4D8-4001-83FF-3DA457ACCE7C

P1476

Q33873672-88A0AFD5-56D7-4431-B2A6-7B9C284AE230

P2093

Q33873672-00D4BEFB-D830-4778-9168-6E7120BDC50A

Q33873672-0DD43E6F-8CC3-434D-BA6D-0811A2347D01

Q33873672-723BA374-E3D0-4B52-A0AA-FDE6F72B91AE

Q33873672-A17477C6-21D0-42F7-9734-0F32169BC4CF

Q33873672-B0A732B7-6460-4197-8DC6-8C3A24851F02

Q33873672-DD695B24-3CC8-40F9-98BA-01D11F91594F

P2860

Q33873672-00A6B69D-99AD-41DC-8522-63790037097D

Q33873672-0FB37A6E-15D2-4848-A9E2-6E8DF1CFA8EE

Q33873672-1716C5F0-82BE-4D32-B933-C82485B154C2

Q33873672-24409471-A3E0-4C2B-AF69-B27A02029811

Q33873672-25DC4645-D6CD-4AE9-83DD-8A4B11D9CAF2

Q33873672-4395F68D-A23B-47DD-8109-97D9165A8DE7

Q33873672-4DB2C433-7BC6-4E91-AD94-6BAD2031125E

Q33873672-4E7ED1FB-6ABB-4E0C-8CFD-27B3E4312119

Q33873672-4FDBFD40-BD69-44F3-A7B7-01FBDBE68275

Q33873672-552BC37D-560A-4A27-A8DE-1405C9650439

P2888

Q33873672-9A2C9247-706A-4A75-9D8E-9C2BC0A994BB

P304

Q33873672-CA9C4F15-C5A8-48C1-A973-6B574219FD0B

P31

Q33873672-DC93F079-098F-4347-891D-23DAB694BB17

P356

Q33873672-6D5D935D-5593-4BF5-91A5-79746671E763

P433

Q33873672-FE000ED4-3A3E-4CF4-B35A-22EFBB4E42B5

P478

Q33873672-B38931B9-54E2-4D1B-A922-DE4B080F6D30

P50

Q33873672-311C307D-4766-4BAD-BCA2-600701F7B00F

P577

Q33873672-FAB26972-4FBE-4AAA-BA00-12617405D060

P5875

Q33873672-99F49D56-5912-4CA6-AAAD-0D6C4CDB5F92

P6179

Q33873672-406BA8BA-E6B7-4ACC-90E8-596F78884B3B

P698

Q33873672-502B8C0A-D499-4AE1-AA6C-00AA6F11E349

P932

Q33873672-F5D155DC-66CD-4F68-AE74-93DDC6235FBB

P356

P1433

Arthritis Research and Therapy

P1476

CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis

@en

P2093

Changyong Feng

http://www.w3.org/2001/XMLSchema#string

Christopher T Ritchlin

http://www.w3.org/2001/XMLSchema#string

Edward M Schwarz

http://www.w3.org/2001/XMLSchema#string

Michael Thullen

http://www.w3.org/2001/XMLSchema#string

Tianmeng Shao

http://www.w3.org/2001/XMLSchema#string

Yahui Grace Chiu

http://www.w3.org/2001/XMLSchema#string

P2860

Exploring the full spectrum of macrophage activation

Monocyte and macrophage heterogeneity

Genetic regulation of osteoclast development and function

Membrane rafts and signaling by the multichain immune recognition receptors.

The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients.

Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.

The CD14+ CD16+ blood monocytes: their role in infection and inflammation.

Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.

Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.

Early psoriatic arthritis.

P2888

P304

R14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR2915

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41147635

http://www.w3.org/2001/XMLSchema#string

P6179

1025585344

http://www.w3.org/2001/XMLSchema#string

P698

20102624

http://www.w3.org/2001/XMLSchema#string

P932

2875642

http://www.w3.org/2001/XMLSchema#string